NT-proBNP to Assess Trastuzumab-induced Cardiotoxicity

Clinical trial NCT06340516 · RECRUITING

Trial details

NCT number: NCT06340516
Sponsor: Vastra Gotaland Region
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Cardiotoxicity Breast Cancer Treatment Side Effects

Start date: 2024-03-14
Primary completion: 2029-03-14
Enrollment: 700

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.